BioSpace News Archive

ACADIA Pharmaceuticals Inc. announced the closing of its previously announced underwritten public offering of 7,187,500 shares of its common stock, which includes 937,500 shares of common stock sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, at a public offering price of $40.00 per share.

Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced the closing of its previously announced initial public offering (IPO) of 26,768,000 shares of its common stock at a price to the public of $22.00 per share.

Encompass Health Corporation (NYSE: EHC) today issued notice for redemption of $400 million of the outstanding principal balance of its 5.75% senior notes due 2024 (the “2024 Notes”).

Vizient, Inc. today announced the winners of their Bernard A. Birnbaum, MD, Quality Leadership Award and Ambulatory Care Quality and Accountability Award for 2019.

Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), today announced the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending approval of the marketing authorisation application (MAA) for Rhokiinsa® (netarsudil ophthalmic solution) 0.02%

Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”), China’s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2019 annual general meeting of shareholders at its Hong Kong office located at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that The Lancet has published detailed positive results from two Phase 3 trials evaluating the safety and efficacy of Dupixent® (dupilumab) in adults with recurring severe chronic rhinosinusitis with nasal polyps (CRSwNP) despite previous treatment with surgery and/or systemic corticosteroids.

Bristol-Myers Squibb Company (NYSE: BMY) will host a webcast on Saturday, September 28, 2019 at 7:30 p.m. CEST (1:30 p.m. EDT) to discuss data presented at the European Society of Medical Oncology, in Barcelona, Spain.

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), the leading developer of spider silk based fibers, announces today that it has selected Ms. Julie Bishop for its expanded Board of Directors

Celgene Corporation (NASDAQ: CELG) today announced an additional ten programs selected for funding under its Celgene Cancer Care Links™ program, an initiative designed to support healthcare capacity building in resource-constrained countries around the world.